K

Kilitch Drugs (India) Ltd
NSE:KILITCH

Watchlist Manager
Kilitch Drugs (India) Ltd
NSE:KILITCH
Watchlist
Price: 335.4 INR 0.77% Market Closed
Market Cap: 5.9B INR

Kilitch Drugs (India) Ltd
Total Other Income

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Kilitch Drugs (India) Ltd
Total Other Income Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Other Income CAGR 3Y CAGR 5Y CAGR 10Y
K
Kilitch Drugs (India) Ltd
NSE:KILITCH
Total Other Income
₹111.4m
CAGR 3-Years
58%
CAGR 5-Years
29%
CAGR 10-Years
N/A
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
Total Other Income
₹12.5B
CAGR 3-Years
6%
CAGR 5-Years
35%
CAGR 10-Years
24%
Cipla Ltd
NSE:CIPLA
Total Other Income
₹10.4B
CAGR 3-Years
40%
CAGR 5-Years
30%
CAGR 10-Years
19%
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Total Other Income
₹20.1B
CAGR 3-Years
47%
CAGR 5-Years
26%
CAGR 10-Years
11%
Lupin Ltd
NSE:LUPIN
Total Other Income
₹2.8B
CAGR 3-Years
59%
CAGR 5-Years
-5%
CAGR 10-Years
2%
T
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
Total Other Income
-₹487.3m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Kilitch Drugs (India) Ltd
Glance View

Market Cap
5.5B INR
Industry
Pharmaceuticals

Kilitch Drugs (India) Ltd. engages in the manufacture and sale of pharmaceuticals, medicinal chemical, and botanical products. The company is headquartered in Mumbai, Maharashtra. The company is primarily engaged in the development, manufacturing, and marketing of finished dosages. The Company’s products include parenteral solutions, effervescent, nutritional products, and medical device. Its products categories include urinary alkalizer, cephalosporins products, gastroenterology, non steroidal anti-inflammatory drugs (NSAIDs), anticonvulsant/antiepileptic, adrenergic agonist, neurotonic, muscle relaxant/stimulant, aminoglycosides, anti-infective, anti-inflammatory, anti-malarials, anti-hypertensive, anaesthetic, uterine stimulants. Its parenteral solutions include neurotonic, veterinary products, metered nasal drops, vaccines, oncology, and ophthalmic products. Its effervescent products include Roipar, Duregra, And Roivit. The firm offers nutritional products, such as Celtine. The firm also offers medical devices, such as C-Seal.

KILITCH Intrinsic Value
329.45 INR
Overvaluation 2%
Intrinsic Value
Price
K

See Also

What is Kilitch Drugs (India) Ltd's Total Other Income?
Total Other Income
111.4m INR

Based on the financial report for Jun 30, 2025, Kilitch Drugs (India) Ltd's Total Other Income amounts to 111.4m INR.

What is Kilitch Drugs (India) Ltd's Total Other Income growth rate?
Total Other Income CAGR 5Y
29%

Over the last year, the Total Other Income growth was 72%. The average annual Total Other Income growth rates for Kilitch Drugs (India) Ltd have been 58% over the past three years , 29% over the past five years .

Back to Top